ArticleJournal of gastrointestinal oncology2016

Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib.

Anant Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.